Heiko Nalenz

Feb 1, 2024 | pharmaceuticalonline.com | Samantha N. Atkinson |Claudia Müller |Heiko Nalenz |Roman Mathaes

Quality management maturity is an important new trend in the biopharmaceutical industry, lauded as the latest evolution in quality management systems and, as recently as September 2023, enshrined in the FDA’s regulatory documents as a defined assessment protocol. Supercharge Your Supply Chain: Harness AI To Gain Competitive AdvantageThe success of CGTs hinges upon adherence to specific logistics protocols.